Mode of action of alanosine

https://doi.org/10.1016/0006-2952(68)90246-3Get rights and content

Abstract

Alanosine inhibits the synthesis of RNA adenine from formate-14C and from glycine-14C in Ehrlich ascites tumor cells in vivo. There is no appreciable depression of the rate of RNA guanine synthesis. The incorporation of preformed adenine-14C into RNA purines is unaffected. Inhibition of RNA adenine synthesis is not antagonized by glutamine or aspartate. The incorporation of thymidine-3H, uridine-3H, and l-leucine-14C into the acid-insoluble fraction of the cells in vitro is unaffected by the drug. Evidence indicates that alanosine may interfere with the conversion of inosine monophosphate to adenosine monophosphate.

References (7)

  • L.L. Bennett et al.

    Archs Biochem. Biophys.

    (1956)
  • B. Levenberg et al.

    J. biol. Chem.

    (1957)
  • E.D. Korn
There are more references available in the full text version of this article.

Cited by (37)

  • EFA(9-β-D-erythrofuranosyladenine) is an effective salvage agent for methylthioadenosine phosphorylase-selective therapy of T-cell acute lymphoblastic leukemia with L-alanosine

    2006, Blood
    Citation Excerpt :

    Furthermore, normal cells abundant in MTAP can be rescued from the toxicity of inhibitors of de novo AMP synthesis by the provision of exogenous MTAP substrates that provide a source of adenine. L-alanosine is a potent inhibitor of de novo AMP synthesis.21-24 The metabolite of L-alanosine, L-alanosinyl-5-amino-4-imidazole carboxylic acid ribonucleotide (L-alanosinyl-AICOR), is a strong inhibitor of adenylosuccinate synthase, which converts IMP to AMP.

  • ATP depletion affects NPM translocation and exportation of rRNA from nuclei

    1996, Biochemical and Biophysical Research Communications
View all citing articles on Scopus

Aided by Grant GM-13958 from the National Institutes of Health, United States Public Health Service.

View full text